SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-020140
Filing Date
2019-07-23
Accepted
2019-07-23 19:58:07
Documents
2
Period of Report
2019-07-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2820
2 EX-24 DOCUMENT attachment1.htm EX-24 4730
  Complete submission text file 0000899243-19-020140.txt   9024
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Issuer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2450 HOLCOME BLVD. SUITE J-608 HOUSTON TX 77021
Business Address
Northrup Jonathan P (Reporting) CIK: 0001770559 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36812 | Film No.: 19969021